Abrotanum
ABROTANUM
ORAL
HUMAN OTC DRUG
Abrotanum is an FDA drug label for the active ingredient ABROTANUM manufactured by Hahnemann Laboratories, INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230628.
- Generic name
- ABROTANUM
- Manufacturer
- Hahnemann Laboratories, INC.
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 37662-3448
- Application
- N/A
- Label effective
- 20230628
Active ingredients
Indications & Usage
Not available.
Dosage & Administration
Not available.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.